NASDAQ: JBIO
Jade Biosciences Inc Stock Ownership - Who owns Jade Biosciences?

Insider buying vs selling

Have Jade Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Tom FrohlichChief Executive Officer2025-05-166,000$7.40
$44.40kBuy

1 of 1

JBIO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when JBIO insiders and whales buy or sell their stock.

JBIO Shareholders

What type of owners hold Jade Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC14.82%4,835,383$34.52MInstitution
Sofinnova Venture Partners X LP11.52%3,758,686$26.84MInsider
Maha Katabi11.52%3,758,686$26.84MInsider
Fairmount Funds Management LLC9.87%3,220,368$22.99MInsider
Fairmount Funds Management LLC9.87%3,220,368$22.99MInstitution
Vr Adviser LLC9.87%3,220,364$22.99MInstitution
Deep Track Capital LP7.69%2,509,301$17.92MInstitution
Atlas Venture Fund XII LP7.13%2,327,909$16.62MInsider
Cormorant Asset Management LP6.22%2,030,691$14.50MInsider
Vanguard Group Inc5.54%1,807,582$12.91MInstitution

1 of 3

JBIO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
JBIO64.18%35.82%Net Buying
CLLS16.23%0.00%
PRQR37.56%0.00%
NMRA26.19%73.81%Net Selling
VYGR52.99%47.01%Net SellingNet Selling

Jade Biosciences Stock Ownership FAQ

Who owns Jade Biosciences?

Jade Biosciences (NASDAQ: JBIO) is owned by 96.72% institutional shareholders, 53.98% Jade Biosciences insiders, and 0.00% retail investors. Sofinnova Venture Partners X LP is the largest individual Jade Biosciences shareholder, owning 3.76M shares representing 11.52% of the company. Sofinnova Venture Partners X LP's Jade Biosciences shares are currently valued at $26.12M.

If you're new to stock investing, here's how to buy Jade Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.